{"id":690398,"date":"2026-05-10T08:03:49","date_gmt":"2026-05-10T06:03:49","guid":{"rendered":"https:\/\/podcast.rs\/epigenetika-dijabetes-i-kancer-dr-melita-vidakovic-dr-aleksandra-uskokovic-i-dr-ana-saric\/"},"modified":"2026-05-10T14:02:39","modified_gmt":"2026-05-10T12:02:39","slug":"epigenetika-dijabetes-i-kancer-dr-melita-vidakovic-dr-aleksandra-uskokovic-i-dr-ana-saric","status":"publish","type":"post","link":"https:\/\/podcast.rs\/en\/epigenetika-dijabetes-i-kancer-dr-melita-vidakovic-dr-aleksandra-uskokovic-i-dr-ana-saric\/","title":{"rendered":"Epigenetika, dijabetes i kancer &#8211; dr Melita Vidakovi\u0107, dr Aleksandra Uskokovi\u0107 i dr Ana Sari\u0107"},"content":{"rendered":"<p>U labu 108 (s04e28)<\/p>\n<\/p>\n<p>Go\u0161\u0107e:<\/p>\n<p>dr. <a href=\"https:\/\/www.ibiss.bg.ac.rs\/sr-yu\/molekularna-biologija\/saradnici\/3975-dr-melita-vidakovic\" target=\"_blank\" rel=\"noopener noreferer\">Melita Vidakovi\u0107<\/a><\/p>\n<p>dr <a href=\"https:\/\/www.ibiss.bg.ac.rs\/sr-yu\/molekularna-biologija\/saradnici\/3967-dr-aleksandra-uskokovic\" target=\"_blank\" rel=\"noopener noreferer\">Aleksandra Uskokovi\u0107<\/a><\/p>\n<p>MSc <a href=\"https:\/\/www.ibiss.bg.ac.rs\/sr-yu\/molekularna-biologija\/saradnici\/3965-ana-saric\" target=\"_blank\" rel=\"noopener noreferer\">Ana Sari\u0107<\/a><\/p>\n<\/p>\n<p>Snimljeno: 2026-05-05 (otprilike)<\/p>\n<p>Mesto: Zadar<\/p>\n<p>Autori: Sr\u0111an, Brane i Milo\u0161<\/p>\n<\/p>\n<p><a href=\"https:\/\/linktr.ee\/ulabu\" target=\"_blank\" rel=\"noopener noreferer\">U labu<\/a><\/p>\n<p><a href=\"https:\/\/discord.gg\/J5ZwstequU\" target=\"_blank\" rel=\"noopener noreferer\">Discord<\/a><\/p>\n<\/p>\n<p>Bele\u0161ke:<\/p>\n<\/p>\n<p>01:30 Uvod<\/p>\n<p>02:50 Go\u0161\u0107e, IBISS, 300 zaposlenih, 14 odeljenja<\/p>\n<p>05:50 Odeljenje za molekularnu biologiju<\/p>\n<p>06:35 Ozempic<\/p>\n<p>07:45 T1D vs T2D<\/p>\n<p>10:40 Ekstrakti protiv T1D<\/p>\n<p>11:20 Epigenetika<\/p>\n<p>14:55 Kratko o razvoju (epi)genetike u 21. veku<\/p>\n<p>17:05 Epigenetika vs T1D<\/p>\n<p>19:10 Stem vs somatske \u0107elije<\/p>\n<p>20:30 Zaklju\u010davanje ARX gena<\/p>\n<p>22:25 Metilacija i CRISPR-Cas (Cas\/makaze treba da bude inaktiviran)<\/p>\n<p>24:05 Metilacija citozina (CpG)<\/p>\n<p>26:05 Selektivnost<\/p>\n<p>26:55 Ube\u0111ivanje alfi da postanu bete, model: mi\u0161<\/p>\n<p>28:45 Epigenetika protiv drugih bolesti, regulativa<\/p>\n<p>30:25 Trostruko negativni karcinom dojke (TNBC)<\/p>\n<p>32:45 Ana poku\u0161ava da pomo\u0107u CRISPR-Cas ubedi TNBC \u0107elije da razviju mete koje zatim mo\u017eemo da ga\u0111amo postoje\u0107im terapijama (PARP inhibitorima)<\/p>\n<p>35:00 PARP<\/p>\n<p>36:40 Apoptoza vs nekroza<\/p>\n<p>37:50 Dopremanje CRISPR-Cas epigeneti\u010dke terapije do \u0107elija pankreasa<\/p>\n<p>40:05 Rezistencija kancera dojke<\/p>\n<p>40:50 Protokoli le\u010denja kancera, trka sa rezistencijom<\/p>\n<p>42:10 Metilacija\/demetilacija<\/p>\n<p>43:40 Hemijsko modifikovanje histona, odnosno proteina (ne samo DNK)<\/p>\n<p>45:30 Mapiranje (epi)genetike, zna\u010daj \u0161irine ekspertize<\/p>\n<p>46:50 \u0160ta go\u0161\u0107e rade u labu<\/p>\n<p>48:30 Struja i Cas9<\/p>\n<p>49:30 Ko pravi CRISPR-Cas<\/p>\n<p>50:20 dr Tomasz Jurkowski<\/p>\n<p>51:40 BH\/B je kul<\/p>\n<p>52:30 Iskustva i perspektive sa COST akcijama Evropske unije<\/p>\n<p>55:30 Saradnja unutar IBISS-a &#8211; btw. slu\u0161ajte Biologiranje, tu je lepo mapiran institut<\/p>\n<p>59:00 Predstavljanje i promocija nauke<\/p>\n<p>1:00:20 Gojaznost<\/p>\n<p>1:01:25 \u0160e\u0107er, neumerenost, \u0161unka, lekovi, stres<\/p>\n<p>1:05:35 Poruke za kraj<\/p>\n<\/p>\n<p><a href=\"https:\/\/tinyurl.com\/s04e28epigen\" target=\"_blank\" rel=\"noopener noreferer\">Reference<\/a> (a\u017eurira\u0107emo)<\/p>","protected":false},"excerpt":{"rendered":"<p>U labu 108 (s04e28) Go\u0161\u0107e: dr. Melita Vidakovi\u0107 dr Aleksandra Uskokovi\u0107 MSc Ana Sari\u0107 Snimljeno: 2026-05-05 (otprilike) Mesto: Zadar Autori: Sr\u0111an, Brane i Milo\u0161 U labu Discord Bele\u0161ke: 01:30 Uvod 02:50 Go\u0161\u0107e, IBISS, 300 zaposlenih, 14 odeljenja 05:50 Odeljenje za molekularnu biologiju 06:35 Ozempic 07:45 T1D vs T2D 10:40 Ekstrakti protiv T1D 11:20 Epigenetika 14:55&#8230;<\/p>","protected":false},"author":3,"featured_media":88484,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[543],"tags":[],"class_list":["post-690398","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-u-labu"],"_links":{"self":[{"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/posts\/690398","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/comments?post=690398"}],"version-history":[{"count":1,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/posts\/690398\/revisions"}],"predecessor-version":[{"id":690403,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/posts\/690398\/revisions\/690403"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/media\/88484"}],"wp:attachment":[{"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/media?parent=690398"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/categories?post=690398"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/podcast.rs\/en\/wp-json\/wp\/v2\/tags?post=690398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}